Stay updated on Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial

Sign up to get notified when there's something new on the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Added a note that recruitment is no longer being pursued and recorded a new record revision v3.6.0; the previous revision v3.5.5 entry was removed.
    Difference
    0.4%
    Check dated 2026-06-13T00:23:59.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The study record history shows a new revision label v3.5.5 added, replacing the prior v3.5.4.
    Difference
    0.1%
    Check dated 2026-06-05T21:48:59.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    A new page revision, v3.5.4, was added to the record history, replacing the previous v3.5.3 and signaling an update to the page's version metadata. This change reflects the latest build of the page rather than core content or functionality.
    Difference
    0.1%
    Check dated 2026-05-15T14:08:06.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The update changes the displayed ClinicalTrials.gov page revision number from v3.5.2 to v3.5.3, reflecting a tooling/interface release rather than a modification to the trial record data.
    Difference
    0.1%
    Check dated 2026-04-24T06:44:11.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Revision: v3.5.2 is now listed, replacing the previous Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:55:42.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    A new version entry was added to the Record History, reflecting updates to the study record such as status, design, eligibility, and contacts/locations.
    Difference
    0.1%
    Check dated 2026-04-09T21:50:31.000Z thumbnail image

Stay in the know with updates to Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page.